As a new-type foreign trade service provider driven by technological transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply DMI from multiple well-known original manufacturers.
As a foreign trade enterprise with R&D capabilities, HiSiaddi is not limited to introducing only its own brands like single-manufacturer factories. We objectively analyze multiple well-known domestic and foreign brands with high global market share and share their major technological progress and breakthroughs, enabling buyers to access authentic, timely and valuable market intelligence.
For more comprehensive and valuable DMI market information, please contact HiSiaddi customer service.
Title: Commercialization of Atmospheric Continuous Production Delivers Significant Improvements to DMI Purity and By-Product Indicators
1.
Breakthrough Details China’s five leading manufacturers have completed transformation from batch autoclave production to full continuous atmospheric synthesis processes, eliminating original high-pressure (1.5MPa) high-temperature reactors. Precisely proportioned ethylenediamine and urea raw materials are fed via automatic control systems, with closed-loop continuous reaction for 5 hours before discharge. By-product dimethylamine and cyclic imine impurity levels have dropped from the original 300–500ppm to ≤35ppm. Industrial-grade DMI purity has risen from 99.2% to 99.75%, while pharmaceutical and electronic premium grades stably reach ≥99.92%. Unit product raw material consumption has decreased by 7.2%, comprehensive production energy consumption reduced by 18.6%, and waste liquid output cut by 32%. All products comply with the latest EU REACH impurity control standards.
2.
3.
Tangible Benefits for Overseas Buyers & End Users (1) Procurement costs: Downstream manufacturing costs have declined, with long-term contract quotations 6%–9% lower than the same period in 2024; marginal costs decrease further for bulk stocking. (2) Production stability: Batch-to-batch purity fluctuation has narrowed from ±0.3% to ±0.05%, eliminating the need for buyers to reserve excess safety stock and cutting capital occupation for warehousing by 12%. (3) Compliance & customs clearance: Impurity indicators meet new European and American pharmaceutical and electronic environmental regulations, eliminating risks of customs detention due to impurity sampling inspections and shortening customs clearance cycles by 2–3 working days.
4.
Title: New Regeneration & Purification Process for Spent DMI Reduces Solvent Loss and End-User Production Costs Simultaneously
1.
Breakthrough Details China’s five major domestic manufacturers have matched supporting rectification + membrane separation coupled recovery facilities for purifying spent DMI returned from downstream production processes. Regenerated DMI reaches 99.6% purity and can be directly blended with virgin material for feeding. The new process cuts single-production system volatile DMI loss from 8.7% to 0.75%, optimizes biodegradability indicators, and raises finished product biodegradation rates from 83% to 92.3%.
2.
3.
Tangible Benefits for Overseas Buyers & End Users (1) End-user factories may source domestic regenerated DMI as a supplementary raw material, lowering total raw material procurement costs by an additional 11%. (2) Massive reduction in on-site VOC emissions complies with ESG environmental assessment standards for European and American factories and avoids environmental penalties. (3) Enhanced supply stability: improved in-house recycling rates boost available export inventory by 15%, significantly mitigating out-of-stock risks during peak demand seasons.
4.
Title: Commercialization of Molecular Distillation Deep Refining Delivers Order-of-Magnitude Improvements to Ultra-Low Metal Ion Indicators for Microelectronics
1.
Breakthrough Details Mitsui Chemicals, BASF and Merck have completed mass production via molecular distillation deep refining. Single metal impurities (Na/K/Fe/Cu) in electronic-specialized DMI have fallen from 10–20ppb to ≤0.5ppb; water content has been optimized from ≤100ppm to ≤12ppm. Ultra-low ion DMI specifications exclusively for semiconductor wafer manufacturing have been developed to support photoresist stripping and precision silicon wafer cleaning for advanced process chips. TCI and Alfa Aesar have upgraded reagent-grade rectification lines, with chromatographic-grade DMI impurity control fully meeting USP and EP pharmacopoeia standards.
2.
3.
Tangible Benefits for Overseas Buyers & End Users (1) Semiconductor buyers: Wafer defect rates during cleaning processes have dropped by 27%, reducing scrap losses. (2) Pharmaceutical API buyers: Side reactions during synthesis of high-end polypeptide and nucleoside pharmaceuticals have decreased, raising product yields by 13%–19%. (3) High-end niche categories: Domestic manufacturers have achieved equivalent mass production of ultra-high-purity specifications, enabling buyers to selectively adopt domestic alternatives to expensive imported raw materials with over 20% cost reduction for high-end feedstocks.
4.
Title: Industrialized Production of Low-Volatility Modified DMI Derivatives Adapted to New Scenarios Including New Energy Electrolytes and Chiral Catalysis
1.
Breakthrough Details Top domestic and international brands have simultaneously launched industrialized production of modified DMI variants: ① Low-volatility modified grade: Trace cycloalkyl additives reduce atmospheric volatility by 65%, suitable for lithium-sulfur battery electrolyte solvents; ② Chiral induction modified DMI: Specialized solvent for asymmetric catalysis, boosting chiral synthesis ee values from the original 89% to above 95.2% for high-end chiral pharmaceutical intermediate production.
2.
3.
Tangible Benefits for Overseas Buyers & End Users (1) New energy battery manufacturers: Improved polysulfide dissolution efficiency in electrolytes extends battery cycle life by 12%, enabling substitution of expensive imported specialty solvents. (2) Fine pharmaceutical enterprises: Simplified chiral API resolution processes eliminate multiple post-purification stages, cutting terminal API production working hours by 20%. (3) Expanded procurement categories: Buyers can source general industrial, pharmaceutical, electronic and modified specialty DMI from a single supplier, streamlining supply chains via one-stop procurement.
4.
Title: Formulation Modification Improves Freezing Point, Resolving Restrictions on Cold-Region Storage & Transportation and Low-Temperature Production
1.
Breakthrough Details Through precise regulation of trace isomers, domestic and foreign brands have reduced the conventional DMI freezing point from the original 8.2°C to -12°C. No crystallization or stratification occurs at -10°C in winter, eliminating blockage of storage tank pipelines during winter in cold regions including Northern Europe and Canada.
2.
3.
Tangible Benefits for Overseas Buyers & End Users (1) Cold-region clients eliminate the need for supporting heating equipment for raw material storage tanks in winter, cutting factory heating energy consumption. (2) No special insulated containers are required for low-temperature ocean shipping, reducing international logistics costs by 7%–10%.
4.
For more comprehensive and valuable DMI market information, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
